ARCHIVES

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

November 9, 2007

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009